Clinical Trial Update: Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update on short-term fasting before PD-1/PD-L1 inhibitor therapy for advanced or metastatic skin cancer. The study status is AC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Cancer

Drugs mentioned

• PD-1/PD-L1 inhibitor (unspecified)

Snippet

Sponsor: University of Southern California | Conditions: Advanced Malignant Skin Neoplasm, Metastatic Malignant Skin Neoplasm | Phase 1 | Status: ACTIVE_NOT_RECRUITING